Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05610332 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 9, 2022 (before its estimated November 1, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To evaluate the clinical efficacy of albumin paclitaxel combined with carelizumab and FLOT in the neoadjuvant treatment of locally advanced gastric cancer with different immune types
Trial Details
NCT Number NCT05610332
Lead Sponsor Fujian Medical University
Conditions
(from sponsor)		 Locally Advanced Gastric Cancer
Enrollment 216 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov